Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017-Reference-Cited by-同舟云学术

Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017

Published:2019-12 Issue: Volume:19 Page:56-63
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Huband Michael D.,Pfaller Michael A.,Shortridge Dee,Flamm Robert K.

Funder

Paratek Pharmaceuticals

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference12 articles.

1. Tetracycline therapy: update;Roberts;Clin Infect Dis,2003

2. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline;Draper;Antimicrob Agents Chemother,2014

3. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline;Honeyman;Antimicrob Agents Chemother,2015

4. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline;Macone;Antimicrob Agents Chemother,2014

5. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections;Villano;Future Microbiol,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of omadacycline dosing regimens in Chinese using population pharmacokinetic-pharmacodynamic analysis;European Journal of Pharmaceutical Sciences;2024-04

2. Antibacterial and anthelmintic activities of Xanthium strumarium (Asteraceae) extracts;Regulatory Mechanisms in Biosystems;2024-02-23

3. Efficacy and safety of omadacycline for treating complicated skin and soft tissue infections: a meta-analysis of randomized controlled trials;BMC Infectious Diseases;2024-02-19

4. Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities;Biomedicines;2023-10-30

5. The pharmacokinetic evaluation of omadacycline (Oral Only Dosing Regimen) for the treatment of Community-Acquired Bacterial Pneumonia (CABP);Expert Opinion on Drug Metabolism & Toxicology;2023-09-02